NCT07639476

Brief Summary

This randomized controlled trial aims to evaluate the efficacy of a universal intervention based on Natural Psychotherapy in reducing anxiety and depressive symptoms among primary and middle school students. To evaluate both the clinical outcomes and the potential underlying mechanisms of change, data will be collected at four distinct time points: baseline (pre-intervention), post-intervention, 3-month follow-up, and 6-month follow-up.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for not_applicable

Timeline
16mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 15, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

11 months

First QC Date

April 13, 2026

Last Update Submit

June 6, 2026

Conditions

Keywords

MindfulnessDepressionEmotional RegulationCognitive FlexibilityPrimary School StudentsMiddle School StudentsFeasibilityNatural Psychotherapy

Outcome Measures

Primary Outcomes (2)

  • Generalized Anxiety Disorder-7 Scale (GAD-7)

    A 7-item self-report scale assessing the severity of anxiety symptoms over the past two weeks. Scores range from 0 to 21, with higher scores indicating more severe anxiety. Clinical cut-off scores are: 0-4 (minimal/no clinical anxiety), 5-9 (mild), 10-14 (moderate),and≥ 15 (severe). This is a widely used, valid, and reliable tool for screening and monitoring anxiety in adolescents. Time points of measurements: (1) Assessment at Week 1 (Pre-intervention, Baseline); (2) Week 5( immediately Post-intervention, after the 4-week intervention period); (3) Week 9 (1-month follow-up); (4) Week 17 (3-month follow-up); (5) Week 29: 6-month follow-up.

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Ruminative Responses Scale (RRS)

    Symptom Rumination: Assesses repetitive focus on the symptoms of distress (e.g., feelings of sadness, fatigue, and loneliness). Brooding: Assesses a moody, reflective style characterized by passive comparison of one's current situation with unachieved standards. Reflective Pondering: Assesses purposeful and reflective examination of one's mood and its causes to gain insight. Scoring: Each item is rated on a 4-point Likert scale from 1 (almost never) to 4 (almost always). Total scores range from 22 to 88. Higher total scores indicate a greater tendency toward rumination. Time points of measurements: (1) Assessment at Week 1 (Pre-intervention, Baseline); (2) Week 5( immediately Post-intervention, after the 4-week intervention period); (3) Week 9 (1-month follow-up); (4) Week 17 (3-month follow-up); (5) Week 29: 6-month follow-up.

    Week 1, Week 5, Week 9, Week 17, Week 29

Secondary Outcomes (9)

  • Mindfulness - Mindful Attention Awareness Scale (MAAS)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Perceived Stress - Perceived Stress Scale (PSS-10)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Resilience - Connor - Davidson Resilience Scale (CD-RISC-10)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Insomnia Severity - Insomnia Severity Index (ISI)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Self-Esteem -Rosenberg Self-Esteem Scale (SES)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • +4 more secondary outcomes

Other Outcomes (4)

  • Positive and Negative Rumination Scale (PANRS)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Executive Function -Self-report Executive Function Scale

    Week 1, Week 5, Week 9, Week 17, Week 29

  • Internet Gaming Disorder Risk - Brief Internet Gaming Disorder Scale (IGDS9-SF)

    Week 1, Week 5, Week 9, Week 17, Week 29

  • +1 more other outcomes

Study Arms (2)

Universal Intervention based on Natural Psychotherapy

ACTIVE COMPARATOR

Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics. Participants will receive a 4-week Multi-model Nature-based Meditation program delivered in regular classrooms. The program consists of weekly group sessions integrating nature-guided imagery exercises with principles of Nature Psychotherapy. Intervention Diary will be collected and will receive response from trained instructors. Sessions are facilitated by trained instructors.

Behavioral: Multi-modal Nature-based MeditationBehavioral: Intervention diary

Standard School Education Control

NO INTERVENTION

Participants assigned to this arm will continue with standard school education as usual (business-as-usual) without the meditation intervention

Interventions

Participants are required to maintain a daily log of their meditation practice and life events, with a particular focus on instances of emotional fluctuation and their corresponding behavioral responses.

Universal Intervention based on Natural Psychotherapy

A 4-week universal group meditation practice delivered in classrooms. The intervention aims to reduce anxiety and depressive symptoms through nature-based mindfulness exercises.

Universal Intervention based on Natural Psychotherapy

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Ages: 7 to 18 years.
  • Population: School-aged children and adolescents currently enrolled and attending primary or secondary school.
  • Capacity: Ability to comprehend the study procedures and provide assent (or consent, if applicable).

You may not qualify if:

  • School Attendance: Children not currently attending school or on long-term academic leave.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Capital Normal University, Beijing

Beijing, Beijing Municipality, 100037, China

Location

Related Publications (3)

  • Koivisto, M. , & Grassini, S. . (2022). Mental imagery of nature induces positive psychological effects. Current Psychology, 1-16.

    BACKGROUND
  • Chen YQ, Li XR, Zhang L, Zhu WB, Wu YQ, Guan XN, Xiu MH, Zhang XY. Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study. J Clin Psychiatry. 2021 May 11;82(3):20m13469. doi: 10.4088/JCP.20m13469.

    PMID: 34004092BACKGROUND
  • Wang DM, Chen DC, Xiu MH, Wang L, Kosten TR, Zhang XY. A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naive first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms. Neuropsychopharmacology. 2024 Apr;49(5):893-902. doi: 10.1038/s41386-023-01760-8. Epub 2023 Oct 30.

    PMID: 37903861BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepressive DisorderPsychological Well-BeingDepressionEmotional Regulation

Condition Hierarchy (Ancestors)

Mental DisordersMood DisordersPersonal SatisfactionBehaviorBehavioral SymptomsSelf-ControlSocial Behavior

Study Officials

  • Xiang-Yang Zhang, Ph.D.

    Tsinghua University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiang-Yang Zhang, Ph.D.

CONTACT

Fangfang Shangguan, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either the intervention group (receiving universal intervention program) or the control group (receiving business-as-usual education).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 13, 2026

First Posted

June 10, 2026

Study Start (Estimated)

September 15, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

June 10, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared. The data are subject to confidentiality agreements due to privacy restrictions.

Locations